期刊文献+

下调结直肠癌细胞受体酪氨酸激酶样孤儿受体抑制细胞生长并促进其凋亡 被引量:3

Down-regulation of receptor-tyrosine-kinase-like orphan receptor 1 suppresses cell growth and enhances apoptosis in human colorectal carcinoma
下载PDF
导出
摘要 目的探讨受体酪氨酸激酶样孤儿受体1(ROR1)在人结直肠癌中的表达及其生物学功能。方法收集60例结直肠癌及对应癌旁组织,实时定量PCR(qRT-PCR)检测ROR1的mRNA水平,免疫组织化学染色检测ROR1的蛋白水平,并分析ROR1蛋白与肿瘤临床病理资料间的相关性。利用ROR1的siRNA特异性敲低结肠癌SW480细胞中ROR1表达,采用qRT-PCR、Western blot法检测ROR1的敲减效果,MTT法检测下调ROR1后,SW480细胞的增殖,异硫氰酸荧光素标记的膜联素Ⅴ/碘化丙啶(annexinⅤ-FITC/PI)双染色结合流式细胞术检测下调ROR1后,SW480细胞的凋亡情况。结果 ROR1在结直肠癌组织中表达水平明显高于对应癌旁组织;结直肠癌组织中ROR1高表达与肿瘤体积增大(≥5 cm)、淋巴结转移及高TNM分期(Ⅲ+Ⅳ期)显著相关;ROR1的siRNA可显著降低SW480细胞ROR1 mRNA及蛋白的水平;下调ROR1表达能够抑制SW480细胞的增殖并促进其凋亡。结论 ROR1在结直肠癌组织中表达上调并与结直肠癌恶性临床病理特征有关,下调ROR1能够抑制结肠癌细胞的生长并促进其凋亡。 Objective To investigate the expression of receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) and its role in cell growth in human colorectal carcinoma (CRC). Methods Real-time quantitative PCR (qRT-PCR) and immuno- histochemistry (IHC) were used to detect the expression of ROR1 in CRC (n =60) and matched tumor-adjacent tissues. The relationship between the expression of ROR1 and clinical features was analyzed by Pearson chi-square test. siRNA was used to down-regulate the expression of ROR1 in SW480 cells in vitro. The qRT-PCR and Western blotting were performed to confirm the down-regulation of ROR1 expression. The effects of down-regulated ROR1 on cell proliferation and apoptosis were measured by MTT assay and flow cytometry combined with annexin V-FITC/PI staining, respectively. Results Both the mRNA and protein expression of ROR1 were significantly up-regulated in CRC tissues than in tumor-adjacent tissues, and the expression of ROR1 was positively correlated with tumor size ( ≥5 cm), lymphatic metastasis and TNM stage (Ⅲ and Ⅳ). siRNA could significantly down-regulate the expression of ROR1 in SW480 cells, then suppressed proliferation and enhanced apoptosis in SW480 cells. Conclusion The expression of ROR1 was significantly higher in CRC tissues than in tumor-adjacent tissues. Down-regulation of ROR1 could play an anti-cancer role through inhibiting proliferation and inducing apoptosis in CRC.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第5期655-659,665,共6页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金面上项目(81171356)
关键词 受体酪氨酸激酶样孤儿受体1 结直肠癌 表达 增殖 凋亡 receptor-tyrosine-kinase-like orphan receptor 1 colorectal carcinoma expression proliferation apoptosis
  • 相关文献

参考文献26

  • 1郑国旭,史圣甲,魏铭,席文锦,郭张燕,杨帆,孟艳玲,温伟红,杨安钢.E盒锌指结合蛋白1基因沉默抑制结肠癌HCT116细胞增殖并促进其凋亡[J].细胞与分子免疫学杂志,2014,30(4):396-398. 被引量:3
  • 2Zhang X, Xu J, Liu H, et al. Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocareinoma: a prospective multicenter phase 2 trial[ J/OL]. Med Oncol, 2014, 31 (10) : 226. doi: 10. 1007/s12032 -014 -0226 - y. Epub 2014 Sep 19.
  • 3Han K, Jin J, Maia M, et al. Lower exposure and faster clearance of bevaeizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase m trial[J]. AKPS J, 2014, 16(5) : 1056 -1063.
  • 4Yamaguchi T, Yanagisawa K, Sugiyama R, et al. NKX2-1/TITF1/ TIT-l-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma [ J ]. Cancer Cell, 2012, 21 ( 3 ) : 348 - 361.
  • 5Hudecek M, Schmitt T M, Baskar S, et al. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to expressa RORl-specific chimeric antigen receptor [ J ]. Blood, 2010, 116(22) : 4532 -4541.
  • 6Hojjat-Farsangi M, Khan A S, Daneshmanesh A H, et al. The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells [ J/OL]. PLoS One, 2013, 8(10) : e78339, doi: 10. 1371/journal. pone. 0078339. eCollection 2013.
  • 7Bicocca V T, Chang B H, Masouleh B K, et al. Crosstalk between ROR1 and the pre-B cell receptor promotes survival of t ( 1 ; 19 ) acute lymphoblastic leukemia [ J ]. Cancer Cell, 2012, 22 ( 5 ) : 656 - 667.
  • 8O'Connell M P, Marehbank K, Webster M R, et al. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma v/a the tyrosine kinase receptors ROR1 and ROR2 [ J ]. Cancer Discov, 2013, 3(12) : 1378 -1393.
  • 9Zhang S, Cui B, Lai H, et al. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy [ J ]. Prec Natl Aead Sei U S A, 2014, 111(48) : 17266 -17271.
  • 10Hudeeek M, Lupo-Stanghellini M T, Kosasih P L, et al. Receptor affinity and extracellular domain modifications affect tumor recognition by RORl-speeific chimeric antigen receptor T cells[ J]. Clin Cancer Res, 2013, 19(12) : 3153 -3164.

二级参考文献33

  • 1Li Q, Wang J, Juzi JT, et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular car- cinoma[ J]. J Gastrointest Surg, 2008, 12 (9) : 1540 - 1547.
  • 2Yang X J, Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention [ J ]. Onco- gene, 2007, 26(37) : 5310 -5318.
  • 3Zhu C, Qin YR, Xie D, et al. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma [ J ]. Oncogene, 2009, 28(31 ) : 2821 -2828.
  • 4Ying MZ, Wang JJ, Li DW, et al. The p3OO/CBP associated factor: is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome [ J ]. Cancer Biol Ther, 2010, 9(4): 312-320.
  • 5Akil A, Ezzikouri S, E1 FA, et al. Associations of genetic variants in the transcriptional eoaetivators EP300 and PCAF with hepatoeellular carcinoma[ J]. Cancer Epidemiol, 2012, 36(5) : e300 - e305.
  • 6Tu K, Zheng X, Zan X, et al. Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma [ J ]. Hepatol Res, 2012, 42 ( 9 ) : 904 - 910.
  • 7Yang XJ, Ogryzko VV, Nishikawa J, et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A [ J ]. Nature, 1996, 382(6589) : 319 -324.
  • 8Sakaguchi K, Herrera JE, Saito S, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade[ J]. Genes Dev, 1998, 12(18) : 2831 -2841.
  • 9Sheppard KA, Rose DW, Haque ZK, et al. Transcriptional activa- tion by NF-kappaB requires multiple coactivators[ J]. Mol Cell Biol, 1999, 19(9): 6367-6378.
  • 10Poux AN, Marmorstein R. Molecular basis for GcnS/PCAF histone acetyltransferase selectivity for histone and nonhistone substrates [ J ]. Biochemistry, 2003, 42(49) : 14366 - 14374.

共引文献28

同被引文献15

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部